Researchers find that a protein in the skin of patients with lupus enables staph bacteria to stick to their skin.
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Examining the autoimmune disease at the molecular level led researchers to a specific molecule that could be contributing to the disease progression in patients.
A new and novel outcome measure is being used to determine effectiveness of new scleroderma treatments. Learn how Michigan Medicine is leading the way.
U-M researchers are studying an overabundant signaling protein tied to UV light sensitivity in patients with lupus.